Zephyr Sleep Technologies

Zephyr offers scientifically-validated medical devices to monitor, analyze and improve sleep performance and effectiveness. Zephyr’s MATRx plus is an FDA approved tablet-based, cloud-connected medical device that identifies obstructive sleep apnea in patients and evaluates the effectiveness of oral appliance therapy for treatment. In a three-step, three-visit platform that streamlines workflow, doctors who use the MATRx plus can determine:
• If the patient has sleep apnea through a home sleep test
• If the patient will be successful with oral appliance treatment through a therapeutic diagnostic test completed by the patient in their home
• How to best configure the oral appliance and eliminate a 30-40% appliance rework rate

The home sleep test and theragnostic system is designed to improve the delivery of oral appliance therapy for those suffering from obstructive sleep apnea (OSA). A sleep study home test and theragnostic identifies patients with OSA who will be effectively treated with an oral appliance, and provides the appliance setting for effective therapy. This simple test enables oral appliance therapy to be nearly 100% effective and reduces the time-to-treatment to 14 days. Regardless of whether the sleep theragnostic is performed in the sleep lab or home, a prescription to proceed with oral appliance therapy can now be provided with confidence and precision.

Company’s Keywords:

obstructive sleep apnea, dental sleep medicine, oral appliance titration, sleep apnea testing, medical devices, sleep medicine, polysomnography, sleep disordered breathing, matrx, matrx plus, sleep dentistry, dentistry, dental, sleep apnea, sleep test, home sleep test, sleep appliance, airway management, biomechanical device, biomedical